Navigation Links
Study Sheds Light on Medication Treatment Options for Bipolar,Disorder

BETHESDA, Md., March 29, 2007--For depressed people with bipolar disorder who are taking a mood stabilizer, adding an antidepressant medication is no more effective than a placebo (sugar pill), according to results published online on March 28, 2007 in the New England Journal of Medicine. The results are part of the large-scale, multi-site Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), a $26.8 million clinical trial funded by the National Institutes of Healths National Institute of Mental Health (NIMH).

Bipolar disorder (http://www.nimh.nih.gov/healthinformation/bipolarmenu.cfm), a sometimes debilitating illness marked by severe mood swings between depression and mania, is usually treated with mood stabilizers such as lithium, valproate, carbamazepine or other medications that reduce mania. However, depression is more common than mania in bipolar disorder, and depressive episodes tend to last longer than episodes of mania. Antidepressant medications are often used in addition to a mood stabilizer for treating bipolar depression, but they are thought to confer a serious risk of a switch from a depressive episode to a manic episode.

Finding the right treatment balance for people with bipolar disorder is a constant challenge; STEP-BD aims to identify the best treatment options. Treating depression in people with bipolar disorder is notoriously difficult, said NIMH Director Thomas R. Insel. STEP-BD sought to determine if adding an antidepressant to a mood stabilizer is effective and safe in treating depressive episodes. The results suggest that antidepressants are safe but not more effective than placebo as assessed in a large number of people with bipolar disorder.

Lead author Gary Sachs, M.D., of Massachusetts General Hospital and colleagues studied 366 participants at 22 sites a
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:2/27/2015)... The role of the Medical Science Liaison ... hasn,t changed: face-to-face meetings are seen as the best ... Leaders. Yet at the same time face-to-face ... interaction, field medical teams within the pharmaceutical sector are ... just one of the challenges addressed in " Medical ...
(Date:2/27/2015)... , Feb. 27, 2015  Acsis Inc., the ... serialization solutions, announced today that John DiPalo , ... Supply & Demand Chain Executive 2015 Provider ... who are leading initiatives to help prepare their companies, ... today,s business climate. This year,s list of Provider Pros ...
(Date:2/27/2015)... Pharmaceuticals, Inc. (Nasdaq: ISIS ) today announced ... loss (NOL) guidance and its cash guidance ending the ... financial results were due in large part to the ... from its partners.  Isis, pro forma NOL of $16.3 ... its 2013 NOL of $40.2 million. On a GAAP ...
Breaking Medicine Technology:Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17
... CITY, Nov. 11 Dynatronics Corporation (Nasdaq: DYNT ... ended September 30, 2009 during the morning of Friday, ... a conference call for investors later that day at ... quarter. Those interested in participating should call 800-861-4084 ...
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... Annual Healthcare Conference on Wednesday, November 18, at 8:30 a.m. ... access a live webcast of the presentation on our website ... is recommended that listeners log on 15 minutes early in ...
Cached Medicine Technology:
(Date:2/28/2015)... February 28, 2015 In a recent ... of Game Change Athlete Development Services ... about the benefits of athlete development and player engagement ... the unique challenges that athletes face and how off-field ... success. , Fletcher became involved in athlete development issues ...
(Date:2/28/2015)... With their commitment to achieving physical results and ... to their already robust library of oblique exercises. “Rope ... as, is often performed on a stationary piece of ... relatively safe manner and can be performed by individuals ... of “Rope Pulls” is located in the oblique exercises ...
(Date:2/28/2015)... 2015 The Classic Denture Center ... new special. Throughout all of March patients can ... This service can help overall mouth health ... Patients may notice certain symptoms that suggest the denture ... symptoms include: , 1.    Pain, clicking, and popping in the ...
(Date:2/28/2015)... Mew and Company, a Vancouver corporate ... provide business consulting services in addition to a variety ... and succession planning. Company finances are a complicated matter ... top of this, complex Canadian tax laws can make ... a result, Mew and Company works to advise their ...
(Date:2/28/2015)... February 28, 2015 Indosoft Inc ... suite for Asterisk, are pleased to announce the development ... 5.7 and 5.8 versions of Q-Suite, this new version ... a number of new features to the leading edge ... , Q-Suite 5.9 will add features to enhance security ...
Breaking Medicine News(10 mins):Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2
... The American Thoracic Society has released new official ... idiopathic pulmonary fibrosis (IPF). The statement replaces ATS ... in the epidemiology, etiology, diagnosis and management of ... pharmacologic and non-pharmacologic therapies and palliative care. , ...
... HealthDay Reporter , THURSDAY, March 17 (HealthDay News) ... scanners that emit radiation are tiny, experts say, but disagreement ... mass of travelers who pass through them every year. ... of Radiology , radiation experts David J. Brenner and ...
... cartilage implants created using stem cells can only be ... measure before the almost inevitable need for total joint ... are investigating the possibilities of a biologically-engineered synthetic liquid ... by offering a one stop, permanent solution. ...
... to hospital patients, coordinating and providing direct care and delivering it ... that each of its patient-care units has an adequate number of ... of hours nurses work known as the "target level" ... of patients and their need for care. Too many nurses can ...
... HealthDay Reporter , WEDNESDAY, March 16 (HealthDay News) ... a large hospital, more patients died, a new study discovered. ... nursing shortages and cost-cutting, in that the focus should shift ... research, appearing in the March 17 issue of the ...
... HealthDay Reporter , WEDNESDAY, March 16 (HealthDay ... the nuclear complex in Japan did manage to reach ... the unfolding disaster across the Pacific Ocean will make ... of any radioactive plume reaching the United States are ...
Cached Medicine News:Health News:ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis 2Health News:ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis 3Health News:ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis 4Health News:Not Even Experts Agree on Safety of Airport Scanners 2Health News:Not Even Experts Agree on Safety of Airport Scanners 3Health News:Liquid biomaterials take stem cell therapy to new level 2Health News:Risk of hospital patient mortality increases with nurse staffing shortfalls, study finds 2Health News:Risk of hospital patient mortality increases with nurse staffing shortfalls, study finds 3Health News:When Nurse Staffing Drops, Mortality Rates Rise: Study 2Health News:Radiation From Japan's Nuke Disaster Unlikely to Threaten U.S., Experts Say 2Health News:Radiation From Japan's Nuke Disaster Unlikely to Threaten U.S., Experts Say 3Health News:Radiation From Japan's Nuke Disaster Unlikely to Threaten U.S., Experts Say 4
... Integra 400 plus, innovation means 4 ... reaction cuvettes and im-proved operator ergonomics. ... and ease-of-use required for true workload ... possible with only one analytical platform, ...
... Advia 2400 has minimal ... (as low as 2 ... (40 L/hour) thus maximizing ... universal rack handler facilitates ...
Iron FS Ferene for determination of iron in serum. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P. For automated systems....
Intended for the quantitative determination of iron in serum. Reaction: Endpoint. Wavelength: 595 nm. Linearity: 500 g/dL (89.5 mol/L). Two vials, liquid reagents....
Medicine Products: